(Q44489178)

English

Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Parkinson's disease

1 reference

based on heuristic

inferred from title

substantia nigra

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Srinivasan J

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Schmidt WJ

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

European Journal of Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

2586-2592

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Alterations in drug induced catalepsy and post-decapitation convulsions following brain and spinal cord depletion of norepinephrine by the neurotoxin DSP-4.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Effects of an alpha2 antagonist ina 20-year-old Java monkey with MPTP-induced parkinsonian signs

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

The roles of noradrenaline and dopamine in contraversive circling behaviour seen after unilateral electrolytic lesions of the locus coeruleus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Noradrenergic loss enhances MDMA toxicity and induces ubiquitin-positive striatal whorls.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Region- and neurotransmitter-dependent species and strain differences in DSP-4-induced monoamine depletion in rodents

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Norepinephrine loss selectively enhances chronic nigrostriatal dopamine depletion in mice and rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Effects of pretreatment with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on methamphetamine pharmacokinetics and striatal dopamine losses

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

The role of the locus coeruleus in the development of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

In vivo regulation of dopamine and noradrenaline release by alpha2A-adrenoceptors in the mouse prefrontal cortex

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Behavioral effects of neuroleptics, apomorphine and amphetamine after bilateral lesion of the locus coeruleus in rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disea

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Noradrenergic involvement in dopamine-dependent stereotyped and cataleptic responses in the rat

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of parkinsonian patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Behavioural pharmacology of glutamate receptors in the basal ganglia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Recent physiological and pathophysiological aspects of Parkinsonian movement disorders

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Atipamezole, an alpha2-adrenoceptor antagonist, augments the effects of L-DOPA on evoked dopamine release in rat striatum.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02684.X

21 January 2018

Identifiers

10.1046/J.1460-9568.2003.02684.X

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44489178&oldid=2025587948"